Division of Plastic and Reconstructive Surgery, Stanford University School of Medicine, 770 Welch Road, Suite 400, Palo Alto, CA, 94304, USA.
Division of Plastic and Reconstructive Surgery, Veterans Affairs Palo Alto, Palo Alto, CA, USA.
Breast Cancer Res Treat. 2019 Nov;178(1):177-183. doi: 10.1007/s10549-019-05361-2. Epub 2019 Jul 23.
Despite the growing spotlight on value-based care and patient safety, little is known about the influence of patient-, reconstruction-, and facility-level factors on safety events following breast reconstruction. The purpose of this study is to characterize postoperative complications in light of hospital-level risk factors.
Using the National Inpatient Sample, all patients who underwent free flap and prosthetic breast reconstruction from 2012 to 2014 were identified. Predictor variables included patient demographic and clinical characteristics, type and timing of reconstruction, annual hospital reconstructive volume, hospital bed size, hospital setting (rural vs. urban), and length of stay. Patient safety indicators (PSIs) were based on the Agency for Healthcare Research and Quality's designation of preventable hospital complications: venous thromboembolism, bleeding, wound complications, pneumonia, and sepsis. Logistic models were used to analyze outcomes.
The sample included 103,301 women, of which 27,695 (26.8%) underwent free flap reconstruction. 3.6% of patients experienced ≥ 1 PSI, most commonly wound PSI (4.9% and 2.5% for free flap and prosthetic reconstruction, respectively). Significant predictors of PSIs included rural setting (p < 0.01) and Elixhauser score ≥ 4 (p < 0.01) for the free flap group, and delayed reconstruction (p < 0.01) for the prosthetic group. Annual reconstructive facility volume was not associated with increased odds of PSIs in either prosthetic or free flap reconstruction (p > 0.05).
PSIs were associated with rural hospitals and greater comorbidities for patients undergoing reconstruction with free flaps. Annual reconstructive facility volume was not associated with adverse inpatient outcomes with either method of reconstruction.
尽管越来越关注基于价值的医疗保健和患者安全,但对于患者、重建和医疗机构层面的因素对乳房重建术后安全事件的影响知之甚少。本研究的目的是根据医院层面的风险因素来描述术后并发症。
使用国家住院患者样本,确定了 2012 年至 2014 年期间接受游离皮瓣和假体乳房重建的所有患者。预测变量包括患者人口统计学和临床特征、重建类型和时间、医院每年重建量、医院床位数、医院设置(农村与城市)和住院时间。患者安全指标(PSI)基于医疗保健研究与质量局对可预防的医院并发症的指定:静脉血栓栓塞、出血、伤口并发症、肺炎和败血症。使用逻辑模型分析结果。
样本包括 103301 名女性,其中 27695 名(26.8%)接受了游离皮瓣重建。3.6%的患者经历了≥1 个 PSI,最常见的是伤口 PSI(分别为 4.9%和 2.5%,用于游离皮瓣和假体重建)。PSIs 的显著预测因素包括农村地区(p<0.01)和 Elixhauser 评分≥4(p<0.01),对于游离皮瓣组,以及延迟重建(p<0.01),对于假体组。每年的重建设施数量与假体或游离皮瓣重建的 PSI 发生率增加无关(p>0.05)。
PSIs 与接受游离皮瓣重建的患者的农村医院和更多合并症相关。每年的重建设施数量与两种重建方法的不良住院结果无关。